Literature DB >> 15848636

Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.

M Senzolo1, P Amodio, M C D'Aloiso, S Fagiuoli, F Del Piccolo, D Canova, A Masier, M Bassanello, G Zanus, P Burra.   

Abstract

BACKGROUND: Cirrhotic patients without overt hepatic encephalopathy may have cerebral function alterations called minimal hepatic encephalopathy (MHE). Our goal was to evaluate the role of partial pressure of ammonia (pNH3), neuropsychological, and neurophysiological assessment in detecting cognitive changes in cirrhotic patients awaiting liver transplantation.
MATERIALS AND METHODS: Fourteen cirrhotic patients listed for liver transplant were studied. All patients underwent the neuropsychological battery called PSE. Neurophysiological assessment including spectral EEG (sEEG), evoked potential P300 and pNH3 and venous and arterial ammonia levels was performed in all patients. Four patients were transplanted.
RESULTS: Liver disease etiology was alcoholic in four patients, viral in six mixed in two, and cryptogenic in two. PSE scores revealed MHE in 8 patients; sEEG was altered in 6, and P300 in 1. No correlations were detected between P300, sEEG, and PSE. pNH3 and arterial ammonia levels were significantly higher in the subgroup of patients with altered sEEG and were correlated with theta band increase in sEEG but not with pathological PSE scores or P300 wave abnormalities.
CONCLUSIONS: The combination of sEEG and PSE, and possibly also pNH3 and arterial ammonia, is useful in detecting cerebral function alterations in cirrhotic patients with no apparent encephalopathy, whereas P300 is not. The diagnosis of MHE obtained using the multimodal approach adopted in this study may enable the adequate treatment of these patients prior to surgery, which includes advising them not to drive and adjusting their priority on the waiting list for OLTx in the light of a condition that cannot be evaluated by Child Pugh score and MELD score.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848636     DOI: 10.1016/j.transproceed.2004.12.265

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

2.  Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China.

Authors:  Ji-Yao Wang; Ning-Ping Zhang; Bao-Rong Chi; Yu-Qing Mi; Li-Na Meng; Ying-Di Liu; Jiang-Bin Wang; Hai-Xing Jiang; Jin-Hui Yang; Yun Xu; Xiao Li; Jian-Ming Xu; Guo Zhang; Xin-Min Zhou; Yu-Zheng Zhuge; De-An Tian; Jin Ye; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

3.  Predictors of minimal hepatic encephalopathy in patients with cirrhosis.

Authors:  Praveen Sharma; Barjesh C Sharma
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

4.  The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis.

Authors:  Yuying Zhang; Yikuan Feng; Bin Cao; Qiang Tian
Journal:  Arch Med Sci       Date:  2015-11-20       Impact factor: 3.318

5.  Event-related evoked potential versus clinical tests in assessment of subclinical cognitive impairment in chronic hepatitis C virus.

Authors:  Hanaa Khalaf Fath-Elbab; Elham Ahmed; Dina Fathy Mansour; Wail Talaat Soliman
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-11-20

6.  Prevalence of Covert Hepatic Encephalopathy in A Tertiary Care Centre.

Authors:  Rahul Pathak; Pukar Ghimire; Sabin Thapaliya; Sashi Sharma; Prem Khadga
Journal:  JNMA J Nepal Med Assoc       Date:  2020-01       Impact factor: 0.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.